Skip to Main Content

Paper Details

Incorporating Uremic Solute-mediated Inhibition of OAT1/3 Improves PBPK Prediction of Tenofovir Renal and Systemic Disposition in Patients with Severe Kidney Disease.
Pharm Res
1
2023
CKD, OAT1, OAT1/3, Patients, Severe Kidney Disease, Tenofovir, Uremic, chronic kidney disease, creatinine, hippuric acid, indoxyl sulfate, p-cresol sulfate, patients, renal OAT1, tenofovir
Author NameAffiliation
Jonathan HimmelfarbKidney Research Institute, University of Washington
Jonathan HimmelfarbKidney Research Institute, University of Washington
  • 1 - 2

Datasets

Release 1.2